Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app. Pick your 5 favourite companies, get a daily email with all news updates on them. Full access to our ...

The pharmaceutical giant reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance ...

We will deliver our fully reinvigorated portfolio to market efficiently and maximise the considerable commercial potential, ...

Amazon has officially announced that the much-awaited Great Indian Festival sale is approaching soon. The e-commerce giant is gearing up to offer massive discounts and exciting offers across a ...

It's not even Black Friday yet, but the official Samsung Store is already offering some of the lowest prices all year across its superb range of TVs, phones, headphones, and tablets as part of an ...

A wash sale is a transaction in which an investor sells a losing security to claim a capital loss, and within 30 days before or after the sale, they: Buy substantially the same securities ...

It's never too early to plan your penny-saving with a Steam Sale schedule. In times past, predicting Steam sales was more soothsaying than science, but we're in a beautiful new world of ...

It's almost that time. Black Friday deals will be here before you know it and Walmart is getting a headstart with a massive sale on last year's Black Friday best-sellers. You can score record-low ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Shares in British pharmaceutical giant GSK rose after the company said it resolved a vast majority of lawsuits in the U.S. claiming its discontinued heartburn medicine Zantac caused cancer.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.